Merkel-cell carcinoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up

被引：2
|
作者：
Lugowska, I. [1 ]
Becker, J. C. [2 ,3 ]
Ascierto, P. A. [4 ]
Veness, M. [5 ,6 ]
Blom, A. [7 ]
Lebbe, C. [8 ,9 ,10 ]
Migliano, E. [11 ]
Hamming-Vrieze, O. [12 ]
Goebeler, M. [13 ]
Kneitz, H. [13 ]
Nathan, P. [14 ]
Rutkowski, P. [15 ]
Slowinska, M. [16 ]
Schadendorf, D. [17 ,18 ,19 ,20 ]
Piulats, J. M. [21 ]
Petrelli, F. [22 ]
van Akkooi, A. C. J. [23 ,24 ,25 ]
Berruti, A. [26 ]
机构：
[1] Mar Sklodowska Curie Natl Res Inst Oncol, Dept Early Phase Clin Trials, Warsaw, Poland
[2] Univ Hosp Essen, Dept Translat Skin Canc Res, German Canc Consortium DKTK, Essen, Germany
[3] Deutsch Krebsforsch Zentrum DKFZ, Dept Translat Skin Canc Res, Heidelberg, Germany
[4] Ist Nazl Tumori IRCCS Fdn G Pascale, Dept Melanoma Canc Immunotherapy & Dev Therapeut, Naples, Italy
[5] Univ Sydney, Sydney Med Sch, Sydney, Australia
[6] Westmead Hosp, Dept Radiat Oncol, Sydney, Australia
[7] UVSQ, Univ Paris Saclay, Ambroise Pare Hosp,CARADERM Network, AP HP,EA4340 BECCOH,Dept Gen & Oncol Dermatol, Boulogne, France
[8] Univ Paris Cite, Paris, France
[9] Hop St Louis, AP HP, Dermatooncol & CIC Dept, Paris, France
[10] INSERM U976, Paris, France
[11] San Gallicano Dermatol Inst IRCCS, Dept Plast & Regenerat Surg, Rome, Italy
[12] Netherlands Canc Inst Antoni van Leeuwenhoek, Dept Radiat Oncol, Amsterdam, Netherlands
[13] Univ Hosp Wurzburg, Dept Dermatol Venereol & Allergol, Wurzburg, Germany
[14] Mt Vernon Canc Ctr, Dept Med Oncol, Northwood, England
[15] Maria Sklodowska Curie Natl Res Inst Oncol, Dept Soft Tissue Bone Sarcoma & Melanoma, Warsaw, Poland
[16] Natl Res Inst, Mil Inst Med, Dept Dermatol, Warsaw, Poland
[17] Univ Hosp Essen, Dept Dermatol, Westdeutsch Tumorzentrum WTZ, Essen, Germany
[18] German Canc Consortium DKTK, Partner Site Essen, Essen, Germany
[19] NCT West Campus Essen, Essen, Germany
[20] Univ Alliance Ruhr, Res Ctr One Hlth, Essen, Germany
[21] Univ Barcelona, Inst Catala Oncol ICO, Inst Invest Biomed Bellvitge IDIBELL, Med Oncol Dept,CIBEROnc, Barcelona, Spain
[22] Azienda Socio Sanit Terr ASST Bergamo Oves, Oncol Unit, Treviglio, Italy
[23] Melanoma Inst Australia, Dept Melanoma & Surg Oncol, Sydney, Australia
[24] Univ Sydney, Fac Med & Hlth, Sydney, Australia
[25] Royal Prince Alfred Hosp, Dept Melanoma & Surg Oncol, Sydney, Australia
[26] Univ Brescia, Dept Med & Surg Specialties, Med Oncol Unit, Radiol Sci & Publ Hlth,ASST Spedali Civili, Brescia, Italy
[27] ESMO Guidelines Comm, ESMO Head Off, Via Ginevra 4, CH-6900 Lugano, Switzerland
来源：
ESMO OPEN | 2024年 / 9卷 / 05期
关键词：
clinical practice guideline; diagnosis; follow-up; Merkel-cell carcinoma; treatment recommendation; MOHS MICROGRAPHIC SURGERY; RADIATION-THERAPY; PROGNOSTIC-FACTORS; POLYOMAVIRUS INFECTION; ADJUVANT RADIOTHERAPY; RARE CANCERS; NODE BIOPSY; OPEN-LABEL; T-ANTIGEN; SURVIVAL;
D O I：
10.1016/j.esmoop.2024.102977
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页数：14
相关论文
共 50 条
  • [21] Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Escudier, B.
    Kataja, V.
    ANNALS OF ONCOLOGY, 2010, 21 : v137 - v139
  • [22] Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Casali, P. G.
    Bielack, S.
    Abecassis, N.
    Aro, H. T.
    Bauer, S.
    Biagini, R.
    Bonvalot, S.
    Boukovinas, I.
    Bovee, J. V. M. G.
    Brennan, B.
    Brodowicz, T.
    Martin-Broto, J.
    Brugieres, L.
    Buonadonna, A.
    De Alava, E.
    Dei Tos, A. P.
    Del Muro, X. G.
    Dileo, P.
    Dhooge, C.
    Eriksson, M.
    Fagioli, F.
    Fedenko, A.
    Ferraresi, V.
    Ferrari, A.
    Ferrari, S.
    Frezza, A. M.
    Gaspar, N.
    Gasperoni, S.
    Gelderblom, H.
    Gil, T.
    Grignani, G.
    Gronchi, A.
    Haas, R. L.
    Hassan, B.
    Hecker-Nolting, S.
    Hohenberger, P.
    Issels, R.
    Joensuu, H.
    Jones, R. L.
    Judson, I.
    Jutte, P.
    Kaal, S.
    Kager, L.
    Kasper, B.
    Kopeckova, K.
    Krakorova, D. A.
    Ladenstein, R.
    Le Cesne, A.
    Lugowska, I.
    Merimsky, O.
    ANNALS OF ONCOLOGY, 2018, 29 : 79 - 95
  • [23] Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Escudier, B.
    Porta, C.
    Schmidinger, M.
    Algaba, F.
    Patard, J. J.
    Khoo, V.
    Eisen, T.
    Horwich, A.
    ANNALS OF ONCOLOGY, 2014, 25 : 49 - 56
  • [24] Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up*
    Kraemer, A.
    Bochtler, T.
    Pauli, C.
    Baciarello, G.
    Delorme, S.
    Hemminki, K.
    Mileshkin, L.
    Moch, H.
    Oien, K.
    Olivier, T.
    Patrikidou, A.
    Wasan, H.
    Zarkavelis, G.
    Pentheroudakis, G.
    Fizazi, K.
    ANNALS OF ONCOLOGY, 2023, 34 (03) : 228 - 246
  • [25] Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
    Vogel, A.
    Bridgewater, J.
    Edeline, J.
    Kelley, R. K.
    Klumpen, H. J.
    Malka, D.
    Primrose, J. N.
    Rimassa, L.
    Stenzinger, A.
    Valle, J. W.
    Ducreux, M.
    ANNALS OF ONCOLOGY, 2023, 34 (02) : 127 - 140
  • [26] Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
    Cervantes, A.
    Adam, R.
    Rosello, S.
    Arnold, D.
    Normanno, N.
    Taieb, J.
    Seligmann, J.
    De Baere, T.
    Osterlund, P.
    Yoshino, T.
    Martinelli, E.
    ANNALS OF ONCOLOGY, 2023, 34 (01) : 10 - 32
  • [27] Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Casali, P. G.
    Blay, J. Y.
    Abecassis, N.
    Bajpai, J.
    Bauer, S.
    Biagini, R.
    Bielack, S.
    Bonvalot, S.
    Boukovinas, I
    Bovee, J. V. M. G.
    Boye, K.
    Brodowicz, T.
    Buonadonna, A.
    De Alava, E.
    Dei Tos, A. P.
    Del Muro, X. G.
    Dufresne, A.
    Eriksson, M.
    Fedenko, A.
    Ferraresi, V
    Ferrari, A.
    Frezza, A. M.
    Gasperoni, S.
    Gelderblom, H.
    Gouin, F.
    Grignani, G.
    Haas, R.
    Hassan, A. B.
    Hindi, N.
    Hohenberger, P.
    Joensuu, H.
    Jones, R. L.
    Jungels, C.
    Jutte, P.
    Kasper, B.
    Kawai, A.
    Kopeckova, K.
    Krakorova, D. A.
    Le Cesne, A.
    Le Grange, F.
    Legius, E.
    Leithner, A.
    Lopez-Pousa, A.
    Martin-Broto, J.
    Merimsky, O.
    Messiou, C.
    Miah, A. B.
    Mir, O.
    Montemurro, M.
    Morosi, C.
    ANNALS OF ONCOLOGY, 2022, 33 (01) : 20 - 33
  • [28] Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Jelic, S.
    Sotiropoulos, G. C.
    ANNALS OF ONCOLOGY, 2010, 21 : v59 - v64
  • [29] Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Vogel, A.
    Cervantes, A.
    Chau, I.
    Daniele, B.
    Llovet, J.
    Meyer, T.
    Nault, J. -C.
    Neumann, U.
    Ricke, J.
    Sangro, B.
    Schirmacher, P.
    Verslype, C.
    Zech, C. J.
    Arnold, D.
    Martinelli, E.
    ANNALS OF ONCOLOGY, 2018, 29 : 238 - 255
  • [30] ESMO-EURACAN Clinical Practice Guideline update for nasopharyngeal carcinoma: adjuvant therapy and first-line treatment of recurrent/metastatic disease
    Bossi, P.
    Chan, A. T.
    Even, C.
    Machiels, J. -P.
    ANNALS OF ONCOLOGY, 2023, 34 (03) : 247 - 250
12345